Warren Eric

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$7,460.00
Insider Sells Quantity
20
Insider Sells Sum
$52,004.90

Insider Activity of Warren Eric

According to the SEC Form 4 filings, Warren Eric, being in a position of

  1. Chief Commercial Officer at Esperion Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5766 shares for $13,298,
    over all time since 2022-05-17, has bought 1000 shares for $7,460, and sold 14854 shares for $52,005.

The largest purchase of all time was on 2022-08-31 and amounted to 1000 shares of Esperion Therapeutics, Inc. for $7,460.

The largest sale of all time was on 2023-03-07 and amounted to 5090 shares of Esperion Therapeutics, Inc. for $25,730.

Biography of Warren Eric

No biography is available at this moment.

2024-10-17SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
107
<0.0001%
$2.12$227-3.32%
2024-09-17SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
2,608
0.0013%
$1.78$4,650+13.2%
2024-08-19SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
211
0.0001%
$1.95$411-4.21%
2024-07-17SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
108
<0.0001%
$2.59$279-26.72%
2024-06-18SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
2,540
0.0015%
$2.86$7,254-27.57%
2024-05-17SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
192
0.0001%
$2.48$477-12.13%
2023-09-20SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
742
0.0008%
$1.25$924+80.87%
2023-08-18SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
243
0.0003%
$1.41$344+43.79%
2023-07-19SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
106
0.0001%
$1.58$168+33.12%
2023-06-21SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
603
0.0008%
$1.48$894+33.8%
2023-05-17SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
219
0.0003%
$1.62$356-9.09%
2023-04-19SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
115
0.0001%
$1.28$147+15.86%
2023-03-17SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
526
0.0008%
$1.78$937-5.48%
2023-03-07SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
5,090
0.0067%
$5.05$25,730-70.06%
2022-10-18SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
107
0.0001%
$7.69$823-79.61%
2022-09-19SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
255
0.0003%
$6.92$1,765-76.24%
2022-08-31PurchaseEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
1,000
0.0015%
$7.46$7,460-29.89%
2022-08-17SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
199
0.0003%
$6.82$1,356-18%
2022-07-19SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
431
0.0006%
$6.58$2,837-7.94%
2022-06-17SaleEsperion Therapeutics, Inc.
ESPR
Chief Commercial Officer
256
0.0004%
$4.90$1,254+12.41%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.